The Polycomb group protein EZH2 directly controls DNA methylation
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The establishment and maintenance of epigenetic gene silencing is fundamental to cell determination and function. The essential epigenetic systems involved in heritable repression of gene activity are the Polycomb group (PcG) proteins and the DNA methylation systems. Here we show that the corresponding silencing pathways are mechanistically linked. We find that the PcG protein EZH2 (Enhancer of Zeste homolog 2) interacts-within the context of the Polycomb repressive complexes 2 and 3 (PRC2/3)-with DNA methyltransferases (DNMTs) and associates with DNMT activity in vivo. Chromatin immunoprecipitations indicate that binding of DNMTs to several EZH2-repressed genes depends on the presence of EZH2. Furthermore, we show by bisulphite genomic sequencing that EZH2 is required for DNA methylation of EZH2-target promoters. Our results suggest that EZH2 serves as a recruitment platform for DNA methyltransferases, thus highlighting a previously unrecognized direct connection between two key epigenetic repression systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neither did Dnmt3a, another chromatin modifying enzyme that is a PRC2 component and is frequently genetically inactivated in myeloid neoplasms (Fig. 5) (31”
From Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy (2014) · cites this paper as [32]
Citations
Cites
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596
Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex
Müller, J., Hart, C. M., Francis, N. J., Vargas, M. L., Sengupta, A., Wild, B., Miller, E. L., O'Connor, M. B., Kingston, R. E., & Simon, J. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00976-5 · Cited by 1,562
Czermin, B., Melfi, R., McCabe, D., Seitz, V., Imhof, A., & Pirrotta, V. (2002) · Cell · doi:10.1016/s0092-8674(02)00975-3 · Cited by 1,533
Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase
Jackson, J. P., Lindroth, A. M., Cao, X., & Jacobsen, S. E. (2002) · Nature · doi:10.1038/nature731 · Cited by 1,251
Lehnertz, B., Ueda, Y., Derijck, A. A. H. A., Braunschweig, U., Perez-Burgos, L., Kubicek, S., Chen, T., Li, E., Jenuwein, T., & Peters, A. H. F. M. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00432-9 · Cited by 1,245
Role of Histone H3 Lysine 27 Methylation in X Inactivation
Plath, K., Fang, J., Mlynarczyk-Evans, S. K., Cao, R., Worringer, K. A., Wang, H., de la Cruz, C. C., Otte, A. P., Panning, B., & Zhang, Y. (2003) · Science · doi:10.1126/science.1084274 · Cited by 1,195
Cited by
Items 701–800 of 1,004
Epigenetic modifications in osteogenic differentiation and transformation
Thomas, D. M., & Kansara, M. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20850 · Cited by 70
Cao, W., Feng, Z., Cui, Z., Zhang, C., Sun, Z., Mao, L., & Chen, W. (2011) · Cancer · doi:10.1002/cncr.26575 · Cited by 69
Wöhrle, S., Wallmen, B., & Hecht, A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00555-07 · Cited by 69
Causes and Consequences of Age-Related Changes in DNA Methylation: A Role for ROS?
Rang, F. J., & Boonstra, J. (2014) · Biology · doi:10.3390/biology3020403 · Cited by 71
Kron, K. J., Liu, L., Trudel, D., Pethe, V. V., Trachtenberg, J., Fleshner, N. E., Bapat, B. V., & van der Kwast, T. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2901 · Cited by 69
Dietary Flavones as Dual Inhibitors of DNA Methyltransferases and Histone Methyltransferases
Kanwal, R., Datt, M., Liu, X., & Gupta, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162956 · Cited by 69
Epigenetic suppression of E-cadherin expression by Snail2 during the metastasis of colorectal cancer
Hu, Y., Dai, M., Zheng, Y., Wu, J., Yu, B., Zhang, H., Kong, W., Wu, H., & Yu, X. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0592-y · Cited by 69
Epigenetic and transcriptional mechanisms for the regulation of IL-10
Zhang, H., & Kuchroo, V. K. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101324 · Cited by 72
Tateishi, K., Ohta, M., Kanai, F., Guleng, B., Tanaka, Y., Asaoka, Y., Tada, M., Seto, M., Jazag, A., Lianjie, L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0449 · Cited by 69
Ayachi, I. E., Fatima, I., Wend, P., Alva-Ornelas, J. A., Runke, S., Kuenzinger, W. L., Silva, J. D. S., Silva, W., Gray, J. K., Lehr, S., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1069 · Cited by 68
Shikauchi, Y., Saiura, A., Kubo, T., Niwa, Y., Yamamoto, J., Murase, Y., & Yoshikawa, H. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00840-08 · Cited by 68
Epigenetic gene regulation by histone demethylases: emerging role in oncogenesis and inflammation
Kang, M., Mehrazarin, S., Park, N., & Wang, C. (2016) · Oral Diseases · doi:10.1111/odi.12569 · Cited by 68
Campisano, S., la Colla, A. B., Echarte, S. M., & Chisari, A. N. (2019) · Nutrition Research Reviews · doi:10.1017/s0954422418000239 · Cited by 69
Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities
Canale, M., Gardini, A. C., Ulivi, P., Arechederra, M., Berasain, C., Lollini, P., Fernández‐Barrena, M. G., & Avila, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155500 · Cited by 68
Napierala, J. S., Lee, J., & Skalnik, D. G. (2008) · DNA and Cell Biology · doi:10.1089/dna.2007.0714 · Cited by 69
miRNAs as Mediators of Drug Resistance
Haenisch, S., & Cascorbi, I. (2012) · Epigenomics · doi:10.2217/epi.12.39 · Cited by 67
Lei, A., Chen, L., Zhang, M., Yang, X., Xu, L., Cao, N., Zhang, Z., & Cao, Y. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00422 · Cited by 67
Epigenetic DNA-(cytosine-5-carbon) modifications: 5-aza-2′-deoxycytidine and DNA-demethylation
Patra, S. K., & Bettuzzi, S. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909060042 · Cited by 67
The role of the polycomb complex in silencing α-globin gene expression in nonerythroid cells
Garrick, D., Gobbi, M. D., Samara, V., Rugless, M. J., Holland, M. L., Ayyub, H., Lower, K. M., Sloane‐Stanley, J., Gray, N., Koch, C., et al. (2008) · Blood · doi:10.1182/blood-2008-06-161901 · Cited by 67
Enzymology of Mammalian DNA Methyltransferases
Jurkowska, R. Z., & Jeltsch, A. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-43624-1_5 · Cited by 69
Kirby, M. K., Ramaker, R. C., Roberts, B. S., Lasseigne, B. N., Gunther, D. S., Burwell, T. C., Davis, N. S., Gulzar, Z. G., Absher, D., Cooper, S. J., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3252-2 · Cited by 67
Paul, A., Dasgupta, P., Roy, D., & Chaudhuri, S. (2017) · Plant Molecular Biology · doi:10.1007/s11103-017-0636-2 · Cited by 67
Feng, G., Li, J., Yang, Z., Zhang, S., Liu, Y., Zhang, W. Y., Ye, L. H., & Zhang, X. D. (2017) · Oncogene · doi:10.1038/onc.2017.291 · Cited by 67
Shchukina, I., Bagaitkar, J., Shpynov, O., Loginicheva, E., Porter, S. I., Mogilenko, D. A., Wolin, E., Collins, P. L., Demidov, G. M., Artomov, M., et al. (2020) · Nature Aging · doi:10.1038/s43587-020-00002-6 · Cited by 67
Genome-wide hydroxymethylcytosine pattern changes in response to oxidative stress
Delatte, B., Jeschke, J., Defrance, M., Bachman, M., Creppe, C., Calonne, E., Bizet, M., Deplus, R., Marroquí, L., Libin, M., et al. (2015) · Scientific Reports · doi:10.1038/srep12714 · Cited by 59
Self-citationChen, X., Song, N., Matsumoto, K., Nanashima, A., Nagayasu, T., Hayashi, T., Ying, M., Endo, D., Wu, Z., & Koji, T. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2062 · Cited by 66
Epigenetic Silencing of miRNA-338-5p and miRNA-421 Drives SPINK1-Positive Prostate Cancer
Bhatia, V., Yadav, A., Tiwari, R., Nigam, S., Goel, S., Carskadon, S. L., Gupta, N., Goel, A., Palanisamy, N., & Ateeq, B. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3230 · Cited by 67
Epigenetic Silencing Mediated through Activated PI3K/AKT Signaling in Breast Cancer
Zuo, T., Liu, T.-M., Lan, X., Weng, Y., Shen, R. Z., Gu, F., Huang, Y., Liyanarachchi, S., Deatherage, D. E., Hsu, P.-Y., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3573 · Cited by 66
Polycomb proteins in hematologic malignancies
Martin-Perez, D., Piris, M. A., & Sanchez-Beato, M. (2010) · Blood · doi:10.1182/blood-2010-05-267096 · Cited by 65
Kim, J. G., Takeshima, H., Niwa, T., Rehnberg, E., Shigematsu, Y., Yoda, Y., Yamashita, S., Kushima, R., Maekita, T., Ichinose, M., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.022 · Cited by 65
Polycomb CBX7 Directly Controls Trimethylation of Histone H3 at Lysine 9 at the p16 Locus
Li, Q., Wang, X., Lu, Z., Zhang, B., Guan, Z., Liu, Z., Zhong, Q., Gu, L., Zhou, J., Zhu, B., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013732 · Cited by 66
Targeting EZH2 for Cancer Therapy: Progress and Perspective
Li, C. H., & Chen, Y. (2015) · Current Protein and Peptide Science · doi:10.2174/1389203716666150409100233 · Cited by 65
Deciphering the genetic code of DNA methylation
Wang, M., Ngo, V., & Wang, W. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa424 · Cited by 64
Galow, A.-M., & Peleg, S. (2022) · Cells · doi:10.3390/cells11030468 · Cited by 66
Gene mutations and molecularly targeted therapies in acute myeloid leukemia.
Hatzimichael, E. C., Georgiou, G. K., Benetatos, L., & Briasoulis, E. C. (2013) · Europe PMC (PubMed Central) · Cited by 65
You, J. S., Kang, J. K., Seo, D.-W., Park, J. H., Park, J. W., Lee, J. C., Jeon, Y. J., Cho, E. J., & Han, J.-W. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4953 · Cited by 58
EZH 2: an emerging role in melanoma biology and strategies for targeted therapy
Tiffen, J. C., Gallagher, S. J., & Hersey, P. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12280 · Cited by 65
Halaban, R., Krauthammer, M., Pelizzola, M., Cheng, E., Kovacs, D., Sznol, M., Ariyan, S., Narayan, D., Bacchiocchi, A., Molinaro, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004563 · Cited by 58
Stem Cell Origin of Death-from-Cancer Phenotypes of Human Prostate and Breast Cancers
Glinsky, G. V. (2007) · Stem Cell Reviews and Reports · doi:10.1007/s12015-007-0011-9 · Cited by 64
Golbabapour, S., Majid, N. B. A., Hassandarvish, P., Hajrezaie, M., Abdulla, M. A., & Hadi, A. H. A. (2013) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2012.0105 · Cited by 68
Chromatin regulators of genomic imprinting
Weaver, J. R., & Bartolomei, M. S. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.12.002 · Cited by 48
Heller, G., Topakian, T., Altenberger, C., Cerny‐Reiterer, S., Herndlhofer, S., Ziegler, B., Datlinger, P., Byrgazov, K., Bock, C., Mannhalter, C., et al. (2016) · Leukemia · doi:10.1038/leu.2016.143 · Cited by 64
Yamada, L., & Chong, S. (2016) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174416000507 · Cited by 65
Molecular Mechanisms of Hepatoblastoma
Zhang, Y., Solinas, A., Cairo, S., Evert, M., Chen, X., & Calvisi, D. F. (2021) · Seminars in Liver Disease · doi:10.1055/s-0040-1722645 · Cited by 65
Mechanisms of DNA Methylation Regulatory Function and Crosstalk with Histone Lysine Methylation
Tibben, B. M., & Rothbart, S. B. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168394 · Cited by 64
DNA Methyltransferases Inhibitors from Natural Sources
Zwergel, C., Valente, S., & Mai, A. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150825141505 · Cited by 64
O'Hagan, H. M. (2014) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21830 · Cited by 57
Epigenetics of prostate cancer
Li, L. (2007) · Frontiers in bioscience · doi:10.2741/2320 · Cited by 63
Eilertsen, K. J., Power, R. A., Harkins, L. L., & Misica, P. M. (2006) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2006.10.019 · Cited by 64
Yu, Y., Chou, R., Chen, L.-T., Shyu, W., Hsieh, S.-C., Wu, C.-S., Zeng, H.-J., Yeh, S., Yang, D., Hung, S., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.185124 · Cited by 63
A Novel Role of Silibinin as a Putative Epigenetic Modulator in Human Prostate Carcinoma
Anestopoulos, I., Sfakianos, A., Franco, R., Chlichlia, K., Panayiotidis, M. I., Kroll, D. J., & Pappa, A. (2016) · Molecules · doi:10.3390/molecules22010062 · Cited by 63
Chapter 4 Histone Demethylases and Cancer
Kampranis, S. C., & Tsichlis, P. N. (2009) · Advances in cancer research · doi:10.1016/s0065-230x(09)02004-1 · Cited by 63
Yin, H., Ju, Z., Zheng, M., Zhang, X., Zuo, W., Wang, Y., Ding, X., Zhang, X., Peng, Y., Li, J., et al. (2023) · PLOS Biology · doi:10.1371/journal.pbio.3002017 · Cited by 62
“As an epigenetic modifier, DNMT3A usually binds directly to the gene promoter to regulate transcription [38].”
BackgroundZhang, Z.-W., Chen, J., Xia, S., Zhao, H., Yang, J.-B., Zhang, H., He, B., Jiao, J., Zhan, B.-T., & Sun, C. (2018) · Gene · doi:10.1016/j.gene.2018.01.096 · Cited by 62
DNA methylation across the tree of life, from micro to macro-organism
NASRULLAH, N., Hussain, A., Ahmed, S., Rasool, M., & Shah, A. J. (2022) · Bioengineered · doi:10.1080/21655979.2021.2014387 · Cited by 62
Induction of Epigenetic Alterations by Chronic Inflammation and Its Significance on Carcinogenesis
Niwa, T., & Ushijima, T. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380864-6.00002-x · Cited by 62
Angrisano, T., Sacchetti, S., Natale, F., Cerrato, A., Pero, R., Keller, S., Peluso, S., Perillo, B., Avvedimento, V. E., Fusco, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq864 · Cited by 61
Epigenetic mechanisms in epilepsy
Kobow, K., & Blümcke, I. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63326-2.00014-4 · Cited by 63
Role of HOTAIR in the diagnosis and prognosis of acute leukemia
Zhang, Y., Huang, S., Zhou, H., Chen, C., Tian, L.-H., & Shen, J. (2016) · Oncology Reports · doi:10.3892/or.2016.5147 · Cited by 62
Zhang, Z., Nikolai, B. C., Gates, L. A., Jung, S. Y., Siwak, E. B., He, B., Rice, A. P., O’Malley, B. W., & Feng, Q. F. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx550 · Cited by 62
Zhu, Q., Sang, F., Withey, S., Tang, W. W. C., Dietmann, S., Klisch, D., Ramos‐Ibeas, P., Zhang, H., Requena, C. E., Hájková, P., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108735 · Cited by 63
DNMT1 is a required genomic regulator for murine liver histogenesis and regeneration
Kaji, K., Factor, V. M., Andersen, J. B., Durkin, M. E., Tomokuni, A., Marquardt, J. U., Matter, M. S., Hoang, T., Conner, E. A., & Thorgeirsson, S. S. (2016) · Hepatology · doi:10.1002/hep.28563 · Cited by 61
The Molecular Biology of HIV Latency
Khoury, G., Darcis, G., Lee, M. Y.-H., Bouchat, S., Driessche, B. V., Purcell, D. F. J., & Lint, C. M. V. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0484-2_8 · Cited by 61
Epigenetic regulation of killer immunoglobulin–like receptor expression in T cells
Li, G., Yu, M., Weyand, C. M., & Goronzy, J. J. (2009) · Blood · doi:10.1182/blood-2009-01-200170 · Cited by 57
Protein lysine acetylation in cellular function and its role in cancer manifestation
Arif, M., Senapati, P., Shandilya, J., & Kundu, T. K. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.10.002 · Cited by 61
Programming differentiation potential in mesenchymal stem cells
Collas, P. (2010) · Epigenetics · doi:10.4161/epi.5.6.12517 · Cited by 61
Turner, A. W., Cruz, J. D. L., & Morris, K. V. (2008) · Molecular Therapy · doi:10.1038/mt.2008.268 · Cited by 61
Wang, S.-H., Yang, Y., Wu, X., Zhang, M., Weng, M., Zhou, D., Wang, J., & Quan, Z.-W. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.06.019 · Cited by 61
Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma
Ordoñez, R., Kulis, M., Russiñol, N., Chapaprieta, V., Carrasco-Leon, A., García-Torre, B., Charalampopoulou, S., Clot, G., Beekman, R., Meydan, C., et al. (2020) · Genome Research · doi:10.1101/gr.265520.120 · Cited by 55
A Role for EZH2 in Silencing of IFN-γ Inducible MHC2TA Transcription in Uveal Melanoma
Holling, T. M., Bergevoet, M. W. T., Wilson, L., van Eggermond, M. C. J. A., Schooten, E., Steenbergen, R. D. M., Snijders, P. J. F., Jager, M. J., & van den Elsen, P. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5317 · Cited by 61
AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms
Rejeski, K., Duque‐Afonso, J., & Lübbert, M. (2021) · Oncogene · doi:10.1038/s41388-021-01952-w · Cited by 60
Tumor suppressor function of RUNX3 in breast cancer
Chen, L. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24074 · Cited by 60
Telomeric Position Effect—A Third Silencing Mechanism in Eukaryotes
Doheny, J. G., Mottus, R., & Grigliatti, T. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003864 · Cited by 60
Biomarkers in Prostate Cancer Epidemiology
Verma, M. K., Patel, P., & Verma, M. (2011) · Cancers · doi:10.3390/cancers3043773 · Cited by 60
Cho, S., Park, J. S., & Kang, Y. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku788 · Cited by 60
Genetic and Epigenetic Characterization of Pulpal and Periapical Inflammation
Fouad, A. F., Khan, A. A., Silva, R. M., & Kang, M. K. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00021 · Cited by 54
Ma, K. H., Hung, H. A., Srinivasan, R., Xie, H., Orkin, S. H., & Svaren, J. P. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2257-14.2015 · Cited by 60
EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer
Chinaranagari, S., Sharma, P., & Chaudhary, J. (2014) · Oncotarget · doi:10.18632/oncotarget.2262 · Cited by 59
Liu, C., Shi, X., Wang, L., Wu, Y., Jin, F., Bai, C., & Song, Y. (2014) · Tumor Biology · doi:10.1007/s13277-014-1804-5 · Cited by 59
Cytosine methylation and hydroxymethylation mark DNA for elimination in Oxytricha trifallax
Bracht, J. R., Perlman, D. H., & Landweber, L. F. (2012) · Genome biology · doi:10.1186/gb-2012-13-10-r99 · Cited by 59
Precision medicine driven by cancer systems biology
Filipp, F. V. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9662-4 · Cited by 62
The DNA methylation landscape of hematological malignancies: an update
Blecua, P., Martinez‐Verbo, L., & Esteller, M. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12744 · Cited by 59
Self-citationVandegehuchte, M., Coninck, D. I. M. D., Vandenbrouck, T., Coen, W. M. D., & Janssen, C. (2010) · Environmental Pollution · doi:10.1016/j.envpol.2010.07.023 · Cited by 59
Control of IL‐4 expression in T helper 1 and 2 cells
Gilmour, J., & Lavender, P. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02845.x · Cited by 59
Dimerization of DNA methyltransferase 1 is mediated by its regulatory domain
Fellinger, K., Rothbauer, U., Felle, M., Längst, G., & Leonhardt, H. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22071 · Cited by 59
Role of primary aging hallmarks in Alzheimer´s disease
Zhao, J., & Huai, J. (2023) · Theranostics · doi:10.7150/thno.79535 · Cited by 51
Writers, Readers, and Erasers of Epigenetic Marks
Nicholson, T. B., Veland, N., & Chen, T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800206-3.00003-3 · Cited by 58
Fan, H., Zhang, H., Pascuzzi, P. E., & ANDRISANI, O. M. (2015) · Oncogene · doi:10.1038/onc.2015.122 · Cited by 58
Hwang, S., Kim, K. U., Kim, J.-E., Kim, H. H., Lee, M. K., Lee, C. H., Lee, S., Oh, T., & An, S. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.108 · Cited by 58
Wijetunga, N. A., Pascual, M., Tozour, J. N., Delahaye, F., Alani, M. T., Adeyeye, M., Wolkoff, A. W., Verma, A. K., & Greally, J. M. (2016) · Oncogene · doi:10.1038/onc.2016.340 · Cited by 58
Jung, H.-J., Byun, H., Jee, B. A., Min, S., Jeoun, U., Lee, Y., Seo, Y., Woo, H. G., & Yoon, G. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.750539 · Cited by 58
DNA methylation in mouse embryonic stem cells and development
Latham, T., Gilbert, N., & Ramsahoye, B. H. (2007) · Cell and Tissue Research · doi:10.1007/s00441-007-0537-9 · Cited by 59
Methylation-Based Therapies for Colorectal Cancer
Cervena, K., Siskova, A., Buchler, T., Vodicka, P., & Vymetalkova, V. (2020) · Cells · doi:10.3390/cells9061540 · Cited by 57
“Moreover, polycomb (PcG) proteins can directly bind to DNMTs and thus regulate their activity [80].”
BackgroundYang, Z., Xu, F., Wang, H., Teschendorff, A. E., Xie, F., & He, Y. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103399 · Cited by 57
The Importance of Networking: Plant Polycomb Repressive Complex 2 and Its Interactors
Godwin, J., & Farrona, S. (2022) · Epigenomes · doi:10.3390/epigenomes6010008 · Cited by 57
SGI‐110 and entinostat therapy reduces lung tumor burden and reprograms the epigenome
Tellez, C. S., Grimes, M. J., Picchi, M. A., Liu, Y., March, T. H., Reed, M. D., Oganesian, A., Taverna, P., & Belinsky, S. A. (2014) · International Journal of Cancer · doi:10.1002/ijc.28865 · Cited by 57
Concise Review: Leukemia Stem Cells in Personalized Medicine
Guzmán, M. L., & Allan, J. N. (2014) · Stem Cells · doi:10.1002/stem.1597 · Cited by 57
Chromatin maps, histone modifications and leukemia
Neff, T., & Armstrong, S. A. (2009) · Leukemia · doi:10.1038/leu.2009.40 · Cited by 57
Sakurai, T., Bilim, V. N., Ugolkov, A. V., Yuuki, K., Tsukigi, M., Motoyama, T., & Tomita, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.035 · Cited by 57
Qiu, G., Xie, H., Wheelhouse, N., Harrison, D. J., Chen, G. G., Salto‐Tellez, M., Lai, P. B. S., Ross, J. A., & Hooi, S. C. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.11.012 · Cited by 57
Metadata
- Authors
- Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., Bollen, M., Esteller, M., Di Croce, L., de Launoit, Y., & Fuks, F.
- Affiliations
- Université Libre de Bruxelles (BE)
- Spanish National Cancer Research Centre (ES)
- KU Leuven (BE)
- Corresponding author
- Fuks, François
- ORCID
- Venue
- Nature
- Published
- 2005-12-14
- Volume
- 439
- Issue
- 7078
- Pages
- 871-874
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2053421436
- Cited by
- 2,204
- References
- 27
- Citations by year
- 2026: 32 · 2025: 52 · 2024: 60 · 2023: 72 · 2022: 89 · 2021: 110 · 2020: 95 · 2019: 94 · 2018: 95 · 2017: 119 · 2016: 151 · 2015: 134 · 2014: 128 · 2013: 135 · 2012: 164
- FWCI
- 33.51
- Type
- journal article
- Language
- en
- Update notices
- erratum (2007-04-12)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Fédération Wallonie-Bruxelles
- Fondation pour la Recherche Médicale
- Ministerio de Economía y Competitividad
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Keywords
- EZH2, Polycomb group proteins, DNA methylation, DNA methyltransferases, polycomb repressive complex 2, epigenetic silencing, chromatin repression, promoter methylation, protein-protein interaction
- MeSH terms
- Enhancer of Zeste Homolog 2 Protein, DNA (Cytosine-5-)-Methyltransferases, DNA-Binding Proteins, HeLa Cells, Humans, Promoter Regions, Genetic, Protein Binding, Repressor Proteins, Substrate Specificity, Transcription Factors, CpG Islands, DNA Methylation, Gene Silencing, Epigenesis, Genetic, Chromatin Immunoprecipitation, Polycomb-Group Proteins, Polycomb Repressive Complex 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.